Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 3/20 | 0.44 |
| ▸ | BLM | P54132 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7588093 | 0.98 | CYP1A2 (0.64) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL26946426 | 0.95 | CYP1A2 (0.61) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL27588223 | 0.93 | DGKA (0.54) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL11853523 | 0.93 | DGKA (0.54) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL11847129 | 0.93 | DGKA (0.54) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL3764429 | 0.93 | DGKA (0.54) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL20417368 | 0.93 | CYP1A2 (0.64) | CYP1A2HTR2CDGKATHRBBLM | |
| Hydrochloric Acid SCHEMBL11847579 | 0.91 | DGKA (0.52) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL27820695 | 0.91 | HTR2C (0.58) | CYP1A2HTR2CDGKATHRBBLM | |
| SCHEMBL11859829 | 0.88 | CYP1A2 (0.54) | CYP1A2HTR2CDGKATHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200277449-A1 | INJECTABLE HYBRID ALGINATE HYDROGELS AND USES THEREOF | UNIV STRASBOURG (FR) | 2020-09-03 | — | — | US | disclosed |
| US-20200138711-A1 | INJECTABLE HYDROGELS AND USES THEREOF | IHU STRASBOURG INSTITUT HOSPITALO-UNIVERSITAIRE DE STRASBOURG (FR) | 2020-05-07 | — | — | US | disclosed |
| WO-2019053269-A1 | INJECTABLE HYBRID ALGINATE HYDROGELS AND USES THEREOF | UNIVERSITÉ DE STRASBOURG (FR) | 2019-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200138711-A1 | INJECTABLE HYDROGELS AND USES THEREOF | CUTA, CD44, PLOD3 | CYP1A2 2350/4885HTR2C 4671/4885DGKA 2938/4885 |
| US-20200277449-A1 | INJECTABLE HYBRID ALGINATE HYDROGELS AND USES THEREOF | SI, ALPI, PIGS | CYP1A2 3912/4885HTR2C 4724/4885DGKA 2436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.